Unique Ingredient Identifier OJ245FE5EU is listed as a ingredient substance
| RN | 532-32-1 |
| EC | 208-534-8 |
| NCIT | C66541 |
| RXCUI | 56455 |
| PUBCHEM | 517055 |
| MF | C7H5O2.Na |
| INCHI KEY | WXMKPNITSTVMEF-UHFFFAOYSA-M |
| SMILES | [Na+].[O-]C(=O)C1=CC=CC=C1 |
UNII OJ245FE5EU SODIUM BENZOATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | FILM | 0.96 MG |
| BUCCAL | FILM, SOLUBLE | 0.69 MG |
| DENTAL | GEL | 0.08 % |
| DENTAL | PASTE | 0.08 % |
| IM - IV | INJECTION | 10 % |
| INTRAMUSCULAR | INJECTION | 5 % |
| INTRAMUSCULAR | SOLUTION, INJECTION | 4.8 %W/V |
| INTRAVENOUS | EMULSION, INJECTION | 0.1 % |
| INTRAVENOUS | INJECTABLE | 0.07 % |
| IV(INFUSION) | INJECTION | 5 % |
| ORAL | CAPSULE | 0.3 MG |
| ORAL | CAPSULE, HARD GELATIN | 0.11 MG |
| ORAL | CONCENTRATE | 2 MG/1ML |
| ORAL | DROPS | 3 MG/1ML |
| ORAL | EMULSION | NA |
| ORAL | FOR SUSPENSION | 10 MG/5ML |
| ORAL | GRANULE, FOR RECONSTITUTION | 10 MG |
| ORAL | GRANULE, FOR SUSPENSION | 10 MG |
| ORAL | LIQUID | 10.13 mg/10mL |
| ORAL | LIQUID | 1 MG/1ML |
| ORAL | LIQUID,EXTENDED RELEASE | 2 MG/ML |
| ORAL | ORAL SOLUTION DOSAGE FORM | 2.5 mg/5mL |
| ORAL | POWDER | 0.01 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 98 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 20 MG/5ML |
| ORAL | POWDER, FOR RECONSTITUTION | 5 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | 93.32 MG/5ML |
| ORAL | POWDER, FOR SUSPENSION | 20 MG/1ML |
| ORAL | SOLUTION | 90 MG/160ML |
| ORAL | SOLUTION | 15 MG/5ML |
| ORAL | SOLUTION, ELIXIR | 5.02 MG/5ML |
| ORAL | SOLUTION, LIQUID | 1 MG/1ML |
| ORAL | SOLUTION, SYRUP | 5 MG/5ML |
| ORAL | SUSPENSION | 10 MG/5ML |
| ORAL | SUSPENSION | 2.5 mg/1.25mL |
| ORAL | SUSPENSION, DROPS | 2.5 MG/1ML |
| ORAL | SUSPENSION, LIQUID | 10 MG/5ML |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 0.05 % |
| ORAL | SYRUP | 10 MG/1ML |
| ORAL | TABLET | 5 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESC | 60 MG |
| ORAL | TABLET, COATED | 9 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.34 MG |
| ORAL | TABLET, FILM COATED | 0.02 MG |
| ORAL | TABLET, SUSTAINED ACTION | NA |
| RECTAL | ENEMA | 0.1 % |
| RECTAL | GEL | 2.54 % |
| RECTAL | SUPPOSITORY | NA |
| TOPICAL | EMULSION | NA |
| TOPICAL | EMULSION, CREAM | 0.2 %W/W |
| TOPICAL | EMULSION, CREAM | 0.2 %W/W |
| TOPICAL | GEL | 0.24 %W/W |
| TOPICAL | PATCH | NA |
| TOPICAL | SOLUTION | 0.1 %W/V |
| TOPICAL | SPONGE | NA |